Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (741-750 of 831) with videos related to

Pageof 84
Sort By:
Oncology|May 21, 2026
Decision making in intrathecal therapy for leptomeningeal diseaseSusanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.
Acta Neuropathologica|June 27, 2023
A T-cell antigen atlas for meningioma: novel options for immunotherapyGioele Medici, Lena K Freudenmann, Julia Velz, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
Neuro-Oncology|April 14, 2022
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trialAntonio Omuro, Alba A Brandes, Antoine F Carpentier, et al.
Neuro-Oncology|August 12, 2022
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Antonio Dono, et al.
The Lancet. Oncology|February 29, 2024
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort studyAditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Neuro-Oncology|May 30, 2023
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect groupPhilipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|September 4, 2023
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect groupPhilipp Karschnia, Jorg Dietrich, Francesco Bruno, et al.
Pageof 84

Showing results (741-750 of 831) with videos related to

Sort By:
Pageof 84
Oncology|May 21, 2026
Decision making in intrathecal therapy for leptomeningeal diseaseSusanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Neuro-Oncology|June 9, 2026
BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directionsKarisa C Schreck, Macarena I de la Fuente, Mary Jane Lim Fat, et al.
Acta Neuropathologica|June 27, 2023
A T-cell antigen atlas for meningioma: novel options for immunotherapyGioele Medici, Lena K Freudenmann, Julia Velz, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
Neuro-Oncology|April 14, 2022
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trialAntonio Omuro, Alba A Brandes, Antoine F Carpentier, et al.
Neuro-Oncology|August 12, 2022
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Antonio Dono, et al.
The Lancet. Oncology|February 29, 2024
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort studyAditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Neuro-Oncology|May 30, 2023
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect groupPhilipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|September 4, 2023
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect groupPhilipp Karschnia, Jorg Dietrich, Francesco Bruno, et al.
Pageof 84